143 related articles for article (PubMed ID: 10392179)
21. Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease.
Eng C
N Engl J Med; 1996 Sep; 335(13):943-51. PubMed ID: 8782503
[No Abstract] [Full Text] [Related]
22. Thyroid cancer genetics: multiple endocrine neoplasia type 2, non-medullary familial thyroid cancer, and familial syndromes associated with thyroid cancer.
Richards ML
Surg Oncol Clin N Am; 2009 Jan; 18(1):39-52, viii. PubMed ID: 19056041
[TBL] [Abstract][Full Text] [Related]
23. Molecular advances in medullary thyroid cancer diagnostics.
Hubner RA; Houlston RS
Clin Chim Acta; 2006 Aug; 370(1-2):2-8. PubMed ID: 16519882
[TBL] [Abstract][Full Text] [Related]
24. [Lump in the neck: 4 patients with a medullary thyroid carcinoma].
Jansen M; Jansen-Schillhorn van Veen JM; Vroom TM; van Vroonhoven TJ; Lips CJ
Ned Tijdschr Geneeskd; 2001 Nov; 145(46):2234-41. PubMed ID: 11757248
[TBL] [Abstract][Full Text] [Related]
25. Thyroidectomy for medullary carcinoma in MEN 2A: positive genetic screening as the sole indicator for surgery.
McNally D; Campbell WJ; Sloan JM; Morrison PJ; Russell CF
Ulster Med J; 1997 Nov; 66(2):134-5. PubMed ID: 9414944
[No Abstract] [Full Text] [Related]
26. [Analysis of mutations in the RET proto-oncogene in patients with medullary thyroid tumor].
Amosenko FA; Brzhezovskiĭ VZh; Liubchenko LN; Shabanov MA; Kozlova VM; Vanushko VE; Kazubskaia TP; Gar'kavtseva RF; Kalinin VN
Genetika; 2003 Jun; 39(6):847-54. PubMed ID: 12884527
[TBL] [Abstract][Full Text] [Related]
27. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
[TBL] [Abstract][Full Text] [Related]
28. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
[TBL] [Abstract][Full Text] [Related]
29. Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2.
Wohllk N; Cote GJ; Evans DB; Goepfert H; Ordonez NG; Gagel RF
Endocrinol Metab Clin North Am; 1996 Mar; 25(1):1-25. PubMed ID: 8907678
[TBL] [Abstract][Full Text] [Related]
30. Predictive DNA testing for multiple endocrine neoplasia 2: a therapeutic challenge of prophylactic thyroidectomy in very young children.
van Heurn LW; Schaap C; Sie G; Haagen AA; Gerver WJ; Freling G; van Amstel HK; Heineman E
J Pediatr Surg; 1999 Apr; 34(4):568-71. PubMed ID: 10235324
[TBL] [Abstract][Full Text] [Related]
31. [Medullary thyroid gland carcinoma. Sporadic/familial. Screening when and why?].
Frilling A; Liedke MO
Internist (Berl); 1998 Jun; 39(6):588-91. PubMed ID: 9677514
[No Abstract] [Full Text] [Related]
32. [Diagnosis and therapy of medullary thyroid carcinoma].
Obara T; Kanbe M; Iihara M; Yamaguchi K; Futami H
Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1202-8. PubMed ID: 9379100
[No Abstract] [Full Text] [Related]
33. Multiple endocrine neoplasia: the Chilean experience.
Diaz RE; Wohllk N
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):7-11. PubMed ID: 22584699
[TBL] [Abstract][Full Text] [Related]
34. Genetic testing and early thyroidectomy for inherited medullary thyroid carcinoma.
Lairmore TC; Frisella MM; Wells SA
Ann Med; 1996 Oct; 28(5):401-6. PubMed ID: 8949970
[TBL] [Abstract][Full Text] [Related]
35. [Preventive thyroidectomy].
Norheim I
Tidsskr Nor Laegeforen; 2000 Nov; 120(27):3235. PubMed ID: 11187158
[No Abstract] [Full Text] [Related]
36. RET proto-oncogene mutation analysis for multiple endocrine neoplasia, type 2.
Takami H
Arch Surg; 1998 Jun; 133(6):679. PubMed ID: 9637472
[No Abstract] [Full Text] [Related]
37. RET protooncogene analysis in the diagnosis of medullary thyroid carcinoma and multiple endocrine neoplasia type II.
Matias-Guiu X
Adv Anat Pathol; 1998 May; 5(3):196-201. PubMed ID: 9868525
[No Abstract] [Full Text] [Related]
38. [Preventive thyroidectomy in hereditary medullary thyroid gland carcinoma].
Görtz G; Kress JH; Schmid KW
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():199-201. PubMed ID: 9101830
[TBL] [Abstract][Full Text] [Related]
39. The MEN II syndromes and the role of the ret proto-oncogene.
Ponder BA; Smith D
Adv Cancer Res; 1996; 70():179-222. PubMed ID: 8902057
[No Abstract] [Full Text] [Related]
40. Thyroid cancers. II. Medullary, anaplastic, lymphoma, sarcoma, squamous cell.
Austin JR; el-Naggar AK; Goepfert H
Otolaryngol Clin North Am; 1996 Aug; 29(4):611-27. PubMed ID: 8844733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
